Navigation Links
USCCB Official Praises Senate Passage of 'Genetic Information Nondiscrimination Act'
Date:4/24/2008

WASHINGTON, April 24 /PRNewswire-USNewswire/ -- The U.S. Senate voted 95 to 0 to pass the Genetic Information Nondiscrimination Act ("GINA," H.R. 493), which bars employers and health insurers from discriminating against individuals on the basis of their own or their family members' genetic information, on April 24.

Deirdre McQuade, Assistant Director for Policy and Communications at the U.S. Conference of Catholic Bishops' (USCCB) Secretariat of Pro-Life Activities, praised its passage.

"Today the Senate took a stand for some of the most vulnerable members of the human family, whether born, yet to be born, or placed for adoption. No one should be discriminated against on the basis of genetic testing," McQuade said.

The House of Representatives overwhelmingly passed a nearly identical bill by a vote of 420 to 3 on April 25, 2007.

"The Pro-Life Secretariat is particularly grateful to Rep. Bart Stupak (D-MI) for ensuring that this bill's protection against discrimination will cover the families of unborn children with adverse prenatal diagnoses, as well as children being adopted," she said. "His advocacy on their behalf will empower families to welcome vulnerable children with special needs into their lives."

"After minor technical differences between the House and Senate bills are resolved, we look forward to President Bush signing into law this important protection for American families," McQuade said.


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat forPro-Life
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
3. Chocolate Milk: The Official Drink of Halloween
4. Easter Seals Awards State and Municipal Public Officials With 2007 Outstanding Advocate Awards
5. D.I.S.C. Scores First Sponsorship Deal as Official Medical Center of the Los Angeles Kings
6. New data on hormone therapy must lead to re-evaluation of official guidelines
7. XTL Announces Delisting From the Official List of the United Kingdom Listing Authority
8. Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA
9. Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Legislators, Health Officials, Breast Cancer Survivors and Activists Call for Action on Breast Cancer
10. Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
11. CDC Reports that Adult Smoking Declines Have Stalled; Elected Officials Should Step up Fight Against Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... The ... the treatment of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, ... while also demonstrating its safety when used at home to combat hair loss. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
(Date:9/1/2015)... ... September 01, 2015 , ... ProRehab Physical Therapy ... their partnership with Apex Physical Therapy (Apex) is official as of ... kind, compassionate, and empathetic care to local residents from their combined eight locations ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes in ... from everyday life changes can lead to very serious, life-altering events. Fortunately nature ... with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses of ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the 18th ... Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in each ... whom work for Calvary, and two junior counselors who were campers themselves just a ...
Breaking Medicine News(10 mins):Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3
... High Commission organized a seminar to explore the possibility ... ventures in services and manufacturing. They invited the // ... lead the discussion with Indian partners in Chennai on ... Hawkins and the group had discussion with healthcare providers ...
... to enable the smooth transfer of microorganisms and biological ... sign for Indian bioscience. But slow implementation of the ... to become the global hub of contract research and ... major player. , ,Discussions in mid-June between acting ...
... HIV during pregnancy because of their own or ... physiological changes during gestation. Irrespective of the mechanism ... HIV acquisition are significantly higher during pregnancy than ... HIV prevention, both to protect mothers from primary ...
... the Indraprastha Apollo Hospital in New Delhi expressed hope that ... successfully separated. // , ,The twins who are joined ... and doctors say that a major impediment to the surgery ... drainage vessel in the brain. Another possible roadblock is the ...
... his/her HIV status, but as far as law goes, you ... the fact that you have to rely on the quality ... ,The Wellington District Court, New Zealand, dismissed the charges of ... nuisance after not disclosing to his female partner his HIV ...
... by Sanofi Pasteur and Merck and found to be ... three doses over 6 months which has shown 100% successful. The ... vaccine protects against Human Papilloma virus infection and also genital warts, ... the market early next year and the profits would be great, ...
Cached Medicine News:Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:Women might be at increased risk of HIV during pregnancy 2Health News:Ruling On Non Disclosure Of HIV Positive Status Is Not Ethical 2Health News:Gardasil vaccine for cervical cancer 2
(Date:9/1/2015)... OR YEHUDA, Israel , Sept. 1, ... HTWR ), a leading innovator of less invasive, miniaturized ... advanced heart failure, announced today that it has entered ... Ltd . ("Valtech").  Valtech is a privately held company ... transcatheter valve repair and replacement devices for the treatment ...
(Date:9/1/2015)... and BRUSSELS , Sept. 1, ... UCB (Euronext Brussels: UCB) today announced top-line results ... RomosozUmab Compared with Teriparatide in postmenopaUsal women with ... with bisphosphonatE therapy). The study (NCT01796301) met the ... favor of romosozumab in the percent change of ...
(Date:9/1/2015)... , Sept. 1, 2015  Dynatronics Corporation ... will present at the First Annual Ladenburg Thalmann ... York City.  Kelvyn H. Cullimore, Jr. , ... leading institutional investment representatives on Tuesday, September 29 ... Ladenburg Thalmann Conference will showcase leading-edge companies in ...
Breaking Medicine Technology:HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Proteolix, Inc. today announced that data from preclinical ... the 2009 ACR/ARHP Annual Scientific Meeting on October 16 ... first in a new class of selective, irreversible proteasome ... clinical trials, including a Phase 2 study in patients ...
... N.J., Oct. 16 The Alabama Supreme Court today overturned ... entry of judgment in favor of NPC. NPC is pleased ... which demonstrates that the State of Alabama,s claims were unfounded. ... by NPC to reporting services resulted in overpayment to pharmacists ...
Cached Medicine Technology:Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 2Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting 3Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court 2Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court 3
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... has developed a range of Milli-Q ... specific water quality requirements. Each of ... designed to specifically target contaminants detrimental ... molecular biology and ICP-MS. The systems ...
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
Medicine Products: